DBV Technologies (DBVT) Treasury Shares (2018 - 2026)
DBV Technologies (DBVT) reported Treasury Shares of $1.0 million for Q1 2026, down 20.82% year-over-year from $1.3 million in Q1 2025, and up 25.0% quarter-over-quarter from $800000.0 in Q4 2025.
DBV Technologies (DBVT) Treasury Shares (2018 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 8 years of Treasury Shares data on file, last reported at $1.0 million in Q1 2026.
- Treasury Shares for Q1 2026 came in at $1.0 million, down 20.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (down 20.82% YoY), and the FY2025 annual result was $800000.0, down 38.88% from the prior year.
- Treasury Shares grew to $1.0 million in Q1 2026 per DBVT's latest filing, from $800000.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $3.8 million in Q1 2026 and troughed at $74680.0 in Q4 2025.
- A 5-year average of $1.1 million and a median of $1.1 million in 2022 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2025: Treasury Shares jumped 75.18% in 2022, then slumped 38.88% in 2025.
- A 5-year view of Treasury Shares shows it stood at $1.1 million in 2022, then increased by 13.89% to $1.3 million in 2023, then advanced by 3.64% to $1.3 million in 2024, then sank by 38.88% to $800000.0 in 2025, then advanced by 25.0% to $1.0 million in 2026.
- Business Quant data shows DBVT's Treasury Shares at $1.0 million in Q1 2026, $800000.0 in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | 3.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 3.76 Mn |
| Mar 31, 2026 | 3.76 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 74,680.00 |
| Dec 31, 2025 | 800,000.00 |
| Dec 31, 2025 | 800,000.00 |
| Dec 31, 2025 | 74,680.00 |
| Sep 30, 2025 | 1.12 Mn |
| Sep 30, 2025 | 159,651.00 |
| Sep 30, 2025 | 159,651.00 |
| Sep 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 2.73 Mn |
| Jun 30, 2025 | 2.73 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 230,513.00 |
| Mar 31, 2025 | 1.26 Mn |
| Mar 31, 2025 | 230,513.00 |
| Mar 31, 2025 | 1.26 Mn |